FDA approves first mRNA seasonal flu vaccine in the US

The US Food and Drug Administration (FDA) has approved the first mRNA-based seasonal flu vaccine in the United States. Earlier, the European Commission had approved a combined mRNA vaccine against seasonal flu and COVID-19 for use in the EU. The approvals mark a significant expansion of mRNA technology beyond the COVID-19 pandemic.